1. Home
  2. MCRB vs ESOA Comparison

MCRB vs ESOA Comparison

Compare MCRB & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCRB
  • ESOA
  • Stock Information
  • Founded
  • MCRB 2010
  • ESOA 2006
  • Country
  • MCRB United States
  • ESOA United States
  • Employees
  • MCRB N/A
  • ESOA N/A
  • Industry
  • MCRB Biotechnology: Pharmaceutical Preparations
  • ESOA Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • MCRB Health Care
  • ESOA Industrials
  • Exchange
  • MCRB Nasdaq
  • ESOA Nasdaq
  • Market Cap
  • MCRB 141.9M
  • ESOA 165.7M
  • IPO Year
  • MCRB 2015
  • ESOA 2006
  • Fundamental
  • Price
  • MCRB $0.72
  • ESOA $9.53
  • Analyst Decision
  • MCRB Hold
  • ESOA
  • Analyst Count
  • MCRB 5
  • ESOA 0
  • Target Price
  • MCRB $4.00
  • ESOA N/A
  • AVG Volume (30 Days)
  • MCRB 840.7K
  • ESOA 201.0K
  • Earning Date
  • MCRB 03-13-2025
  • ESOA 05-07-2025
  • Dividend Yield
  • MCRB N/A
  • ESOA 0.32%
  • EPS Growth
  • MCRB N/A
  • ESOA 161.70
  • EPS
  • MCRB 0.00
  • ESOA 1.44
  • Revenue
  • MCRB N/A
  • ESOA $362,359,788.00
  • Revenue This Year
  • MCRB N/A
  • ESOA $9.95
  • Revenue Next Year
  • MCRB N/A
  • ESOA N/A
  • P/E Ratio
  • MCRB $824.00
  • ESOA $6.64
  • Revenue Growth
  • MCRB N/A
  • ESOA 8.42
  • 52 Week Low
  • MCRB $0.54
  • ESOA $5.70
  • 52 Week High
  • MCRB $1.53
  • ESOA $19.83
  • Technical
  • Relative Strength Index (RSI)
  • MCRB 46.92
  • ESOA 44.62
  • Support Level
  • MCRB $0.69
  • ESOA $9.40
  • Resistance Level
  • MCRB $0.76
  • ESOA $10.48
  • Average True Range (ATR)
  • MCRB 0.05
  • ESOA 0.50
  • MACD
  • MCRB 0.00
  • ESOA 0.09
  • Stochastic Oscillator
  • MCRB 53.55
  • ESOA 44.77

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About ESOA Energy Services of America Corporation

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.

Share on Social Networks: